Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. It also provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, it develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is based in Tel Aviv, Israel. As of August 22, 2025, Xylo Technologies Ltd was taken private.
Frequently asked questions
What sector does XYLO (XYLO) operate in?
XYLO belongs to the Healthcare sector and operates in the Medical Devices industry.
What is XYLO (XYLO) current stock price?
As of the latest data, XYLO stock price is $5.07, with a previous close of $5.07.
What is XYLO (XYLO) current market capitalization?
XYLO market cap is approximately 6.49 million.
What is XYLO (XYLO) Earnings Per Share (EPS)?
The trailing EPS is -$8.00.
Does XYLO (XYLO) pay dividends?
No. XYLO does not pay a dividend.
What is XYLO (XYLO) beta (volatility) score?
XYLO has a beta of 0.171, indicating lower volatility than the overall market.